Sign in

Bret Jardine

Chief Legal Officer and Corporate Secretary at FIRST ADVANTAGE
Executive

About Bret Jardine

Bret T. Jardine (age 58) is Chief Legal Officer and Corporate Secretary of First Advantage (since Nov 2024), after serving as EVP, General Counsel & Corporate Secretary since Jan 2011; he joined First Advantage in Aug 2004 and previously led the First Advantage legal function when it was a division within First American/CoreLogic in 2009–2010. He holds a B.A. in Political Science (University of Florida) and a J.D. (Stetson University College of Law) . The company’s pay-versus-performance section states compensation actually paid has been directionally aligned with TSR since the IPO, and revenues were the “Company-Selected Measure” linking pay to performance in 2024 .

Past Roles

OrganizationRoleYearsStrategic Impact
First Advantage CorporationChief Legal Officer & Corporate SecretaryNov 2024–presentSenior legal executive post-Sterling acquisition and public-company governance .
First Advantage CorporationEVP, General Counsel & Corporate SecretaryJan 2011–Nov 2024Led global legal, corporate governance, supported transactions .
First Advantage business (within First American/CoreLogic)Head of Legal DepartmentNov 2009–Dec 2010Led legal for division through corporate transitions .
First Advantage (public company, earlier incarnation)Acting General Counsel2009Interim GC leadership during public-company period .

External Roles

OrganizationRoleYearsStrategic Impact
Zimmet, Unice, Salzman, Heyman and Jardine PAAttorneyPrior to Aug 2004 (nearly a decade)Class actions, regulatory inquiries, corporate transactions and governance expertise .

Fixed Compensation

Metric202220232024
Base Salary ($)351,750 369,267 387,500
Current Base Rate (as of effective date in 2024)$450,000 (effective Nov 1, 2024)
Target Annual Bonus (% of Salary)50% (adjusted in 2021) 50% 50%
Target Annual Bonus ($)193,750
Actual Annual MICP Bonus ($)67,293 56,300 96,880

Notes:

  • Jardine’s employment letter provides MICP target at 75% originally, adjusted to 50% in 2021, consistent with 2024 target math .
  • Base salary increase from $375,000 to $450,000 effective Nov 1, 2024 .

Performance Compensation

Annual Incentive Plan (MICP) – 2024 Design and Outcome

MetricWeightingTargetActualPayout vs TargetVesting/Payment Timing
Adjusted EBITDA50%Internal target (not disclosed) Not disclosedIncluded in approx 40–50% payout range; Jardine paid 50% of target ($96,880 vs $193,750) Paid post-audit, typically in March following year
Revenue50%Internal target (not disclosed) Not disclosedIncluded in approx 40–50% payout range; Jardine paid 50% of target ($96,880 vs $193,750) Paid post-audit, typically in March following year

Special Transaction Bonus (one-time, Nov 2024)

TriggerAmount ($)Rationale
Completion of Sterling Acquisition (Nov 2024)450,000Special one-time cash transaction bonus in connection with the Sterling acquisition .

Long-Term Equity Incentive Awards (2024 grants)

Grant DateInstrument# Shares/OptionsExercise Price ($)Grant Date FV ($)Vesting Schedule
Mar 4, 2024RSUs3,714 n/a58,718 25% on each of first four anniversaries of Mar 4, 2024
Mar 4, 2024Nonqualified Stock Options7,176 15.81 48,510 25% on each of first four anniversaries of Mar 4, 2024
Nov 14, 2024RSUs5,461 n/a97,479 25% on each of first four anniversaries of Nov 14, 2024
Nov 14, 2024Nonqualified Stock Options11,683 17.85 90,660 25% on each of first four anniversaries of Nov 14, 2024
  • RSUs in 2024 are 100% time-based (no performance-vesting) per the RSU program description .

Equity Ownership & Alignment

Beneficial Ownership (as of Apr 24, 2025)

HolderShares Beneficially Owned% Outstanding
Bret T. Jardine112,046<1%
  • Hedging/Pledging: Company policy prohibits hedging and short sales; pledging or margin requires pre-clearance from the CLO; executive officers must consult the CLO before trading .
  • Ownership guidelines: Not disclosed in cited sections; no specific multiple reported.
  • TSR linkage: Pay-versus-performance disclosure indicates compensation actually paid is directionally aligned with TSR since IPO; revenues selected as 2024 company-selected measure .

Outstanding Equity Awards at FY 2024 Year-End (Dec 31, 2024)

Award TypeGrant DateExercisable Options (#)Unexercisable Options (#)Exercise Price ($)ExpirationUnvested RSUs/Shares (#)Market Value of Unvested ($)
Nonqualified Stock Option2/9/202052,28067,9065.111/31/2030
RSU5/11/202367,9061,271,879
Nonqualified Stock Option5/11/20233,93711,81211.125/11/2033
RSU3/4/202411,812221,239
Nonqualified Stock Option3/4/202407,17615.813/4/2034
RSU11/14/20247,176134,406
Nonqualified Stock Option11/14/2024011,68317.8511/14/2034

Vesting cadence (new grants): 25% annually over four years for both RSUs and time options granted Mar 4, 2024 and Nov 14, 2024 .

Rule 10b5-1 Trading Plan (potential selling pressure)

ExecutivePlan TypeAdoption DateScheduled ExpirationAggregate Shares to be Sold
Bret T. JardineRule 10b5-1 planAug 8, 2025Aug 7, 2026Up to 29,956 shares

Employment Terms

  • Agreement: Employment letter dated Mar 30, 2011; at-will; eligible for MICP (target adjusted to 50% in 2021); base salary increased to $450,000 in 2024 .
  • Severance/Good Reason: If terminated without Cause or resigns for Good Reason, continued base salary for six months, subject to release and covenants . Good Reason generally includes material diminution in duties, reduction in base salary (up to 10% across-the-board reduction permitted under Jardine’s agreement), material relocation, and similar triggers .

Potential Payments on Termination/Change in Control (as of Dec 31, 2024)

ScenarioCash Severance ($)Pro-Rata Bonus ($)Health/Welfare ($)Accelerated Options ($)Accelerated RS/RSUs ($)Total ($)
Without Cause / For Good Reason (No CIC)187,500177,604353,042718,146
Without Cause / For Good Reason in Connection with a CIC187,500187,500
Death or Disability51,88592,807144,692
  • Severance multiple: Six months of base salary (no bonus multiple) .
  • Change-in-control: Table shows no equity acceleration value for Jardine in CIC scenario (as of 12/31/2024) .

Multi‑Year Total Compensation Snapshot (Summary Compensation Table)

Component ($)202220232024
Salary351,750 369,267 387,500
Bonus (MICP and any special)67,293 56,300 546,880 (includes $450,000 one-time transaction bonus)
Stock Awards (RSUs)49,256 156,197
Option Awards82,367 139,170
Non-Equity Incentive Plan Comp
All Other Compensation4,017 4,370 4,522
Total423,060 561,560 1,234,269

Policies and Governance Touchpoints

  • Hedging/short sale prohibition; pledging/margin requires CLO pre-clearance; executive trading requires consultation with CLO; 10b5-1 plans encouraged .
  • Related party transactions policy requires Audit Committee/independent review; executive compensation arrangements overseen by Compensation Committee .
  • Say-on-Pay proposal presented annually; Board recommends “FOR” (approval percentages not disclosed in cited sections) .

Investment Implications

  • Alignment: Jardine’s equity is primarily time-based RSUs and options with standard four-year vesting; no performance-vesting RSUs in 2024, modest severance (6 months salary) and no listed CIC equity acceleration at year-end 2024 reduce “golden parachute” risk but also provide fewer performance-contingent levers; revenues and Adjusted EBITDA are the annual bonus drivers .
  • Selling pressure: A Rule 10b5-1 plan adopted Aug 8, 2025 contemplates sales of up to 29,956 shares through Aug 7, 2026, which may create incremental insider supply during the plan window .
  • Retention risk: Base salary increased to $450,000 effective Nov 1, 2024; equity vesting over four years and a one-time 2024 transaction bonus suggest retention focus post-Sterling acquisition, but severance economics for Jardine are limited (6 months salary) .
  • Ownership: Jardine beneficially owns 112,046 shares (<1%); options and unvested RSUs provide additional exposure; company policy restricts hedging/pledging, supporting alignment though no explicit ownership guideline multiple is disclosed in cited sections .
  • Pay-performance linkage: 2024 MICP paid at 50% of target for Jardine, consistent with company-wide determination tied to revenue and Adjusted EBITDA; pay-versus-performance section asserts directional alignment of compensation actually paid with TSR since IPO, and revenues were the company-selected measure for 2024, anchoring the pay mix to growth metrics .